Conference Details - Agenda
View all Conferences
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Fourth Annual Multidisciplinary Symposium on Head and Neck Cancer
The Rittenhouse Hotel
Philadelphia, PA
December 6, 2008
Saturday, Dec 6, 2008
| 7:30 am | Registration and Continental Breakfast |
| 8:00 am | Welcome and Introductions Ezra Cohen, Merrill Kies, and Dong Shin |
| 8:05 am | Presession Survey |
| Keynote Lecture | |
| 8:10 am | Concurrent Chemoradiation Therapy for Head and Neck Cancer: Which Drugs, Doses, and Schedules Are Best? David Adelstein |
| 8:40 am | Question-and-Answer |
| Head and Neck Cancer Biology: Implications for Therapy | |
| 8:45 am | Molecular Biology of Head and Neck Cancer Bonnie Glisson |
| 9:05 am | Treatment Strategies for HPV-Positive SCCHN Marshall Posner |
| 9:25 am | Panel Discussion |
| 9:45 am | Break |
| Updates in Treatment of Locally Advanced Disease | |
| 10:00 am | Robotics and Minimally Invasive Surgery F. Christopher Holsinger |
| 10:20 am | Radiation Therapy: Current Approaches Walter Curran, Jr |
| 10:40 am | Brachytherapy and Intraoperative Radiation Therapy in the Management of Head and Neck Cancer Louis Harrison |
| 11:00 am | Role of Induction Chemotherapy in Head and Neck Cancer Merrill Kies |
| 11:20 am | Postsession Survey |
| 11:25 am | Case-Based Panel Discussion Chair: John A. Ridge |
| 12:05 pm | Break to Serve Lunch |
| 12:35 pm | Presession Survey |
| Novel Agents in Head and Neck Cancer | |
| 12:40 pm | Optimal Application of EGFR Inhibitors Barbara Burtness |
| 1:00 pm | Novel Agents I: Antiangiogenic Agents Robert Haddad |
| 1:20 pm | Novel Agents II : Novel Therapeutic Targets Tanguy Seiwert |
| 1:40 pm | Development of Nanotechnology in Head and Neck Cancer Treatment Dong Shin |
| 2:00 pm | Case-Based Panel Discussion Chair: Ezra Cohen |
| 2:40 pm | Break |
| Thyroid and Salivary Gland Cancer | |
| 2:55 pm | Advances in Targeted Agents for Thyroid Cancer Ezra Cohen |
| 3:15 pm | Multidisciplinary Approaches to Salivary Gland Cancer Eric J. Sherman |
| 3:35 pm | Postsession Survey |
| 3:40 pm | Panel Discussion |
| 4:00 pm | Adjourn |
Educational Grants
An educational grant for this activity was provided by:
- Bristol-Myers Squibb/
ImClone Systems - Genentech BioOncology/OSI Oncology
- Merck Oncology
- sanofi-aventis U.S.